Scalper1 News
Genomics firm Illumina (ILMN) dipped Monday on news of a competing high-end gene sequencer, while lower-end rival Bio-Reference Laboratories (BRLI) rose despite missing quarterly expectations. At the European Human Genetics Conference over the weekend, Complete Genomics, a unit of BGI (formerly Beijing Genomics Institute), previewed its Revolocity sequencing system, a “supersequencer” designed to deliver as many as 30,000 whole genome sequences Scalper1 News
Scalper1 News